Medtronic discloses 252.8M MiniMed share stake

Medtronic plc filed an initial ownership report for MiniMed Group, Inc., stating indirect beneficial ownership of 252,813,348 shares of MiniMed common stock.

Accepted by SEC EDGAR 03/05/2026 - 08:39 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Medtronic plc filed an initial ownership report for MiniMed Group, Inc., stating indirect beneficial ownership of 252,813,348 shares of MiniMed common stock. This Form 3 does not report new share purchases or sales, but formally records Medtronic as a more than 10% owner.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Medtronic plc

Role 10% Owner

Type	Security	Shares	Price	Value
Holding	Common Stock	--	--	--

Holdings: Common Stock — 252,813,348 shares (Indirect, See remarks.)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Medtronic plc’s Form 3 filing for MiniMed Group (MMED) show?

The Form 3 shows Medtronic plc as a more than 10% owner of MiniMed Group, Inc., reporting indirect beneficial ownership of 252,813,348 MiniMed common shares. It establishes Medtronic’s significant stake rather than detailing new trades.

How many MiniMed Group (MMED) shares does Medtronic report owning?

Medtronic reports indirect beneficial ownership of 252,813,348 shares of MiniMed Group common stock. This figure reflects Medtronic’s stake as recorded on the Form 3 and indicates it is a more than 10% beneficial owner of MiniMed.

Does Medtronic’s Form 3 for MiniMed indicate recent buying or selling?

The Form 3 lists Medtronic’s indirect ownership of MiniMed shares but does not report specific buying or selling transactions. It serves as an initial statement of beneficial ownership rather than a record of recent trades in MiniMed stock.

What type of security is reported in Medtronic’s MiniMed Form 3?

The filing reports ownership of MiniMed Group, Inc. common stock. Medtronic’s Form 3 records indirect beneficial ownership of 252,813,348 common shares, confirming its status as a major shareholder in MiniMed through this class of equity security.

Is Medtronic’s ownership of MiniMed shares direct or indirect?

Medtronic’s Form 3 describes its MiniMed common stock position as indirect ownership, with the nature of ownership referenced as “See remarks.” This indicates the stake is held through related entities or structures rather than directly in Medtronic’s own name.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Medtronic plc

(Last) (First) (Middle)

C/O 710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MN 55432

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/05/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	252,813,348	I	See remarks.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Consists of securities held of record by Medtronic Global Holdings S.C.A., an indirect, wholly-owned subsidiary of Medtronic plc.

	/s/ Brian Sandstrom, VP, Chief Corporate and Securities Counsel	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.